BioCryst Pharmaceuticals | 시가 총액

Market Capitalization 변화 날짜
Alnylam Pharmaceuticals USD 24.02B 1.88B 2023-12
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
Chugai Pharma JPY 8.97T 1.21T 2023-12
Daiichi Sankyo JPY 7.52T 473.2B 2023-12
Enanta Pharmaceuticals USD 198M 37M 2023-12
Gilead Sciences USD 100.94B 7.57B 2023-12
GlaxoSmithKline GBP 59.68B 1.42B 2023-12
Incyte USD 12.89B 1.18B 2024-03
Intra Cellular Therapies USD 6.67B 227M 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Novavax USD 684M 43M 2023-09
PTC Therapeutics USD 2.22B 145M 2024-03
Regeneron Pharmaceuticals USD 106.74B 11.05B 2024-03
Roche Holding CHF 199.67B 23.81B 2023-12
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
Ultragenyx Pharmaceutical USD 3.77B 153M 2024-03
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03



BioCryst Pharmaceuticals 시가 총액 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.